Insider · CIK 0001346981

Cohen Kenneth M

Reports to the SEC for 4 companies · DEL MAR, CA

sec.gov

Transactions

Companies

Filings

CIK

0001346981

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−513 sh	—	—	0
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−513 sh	—	—	0
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+513 sh	—	—	24,552
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+513 sh	—	—	26,808
2018-02-21	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+35K sh	—	—	35,000
2018-01-24	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director	SSale	−18K sh	$0.84	−$15.1K	78,355
2018-01-23	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director	SSale	−17.4K sh	$0.87	−$15.2K	96,351
2017-10-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	Director	AAward	+75.8K sh	—	—	75,790
2017-09-15	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	Director	AAward	+24.2K sh	—	—	24,210
2017-06-12	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+20K sh	$1.57	+$31.4K	20,000
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+50K sh	$1.80	+$90K	50,000
2017-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,543 sh	—	—	7,557
2017-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,543 sh	—	—	1,543
2017-01-01	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+4,100 sh	$3.38	+$13.9K	4,100
2016-08-29	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+4,100 sh	$5.00	+$20.5K	4,100
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	Director	PPurchase	+3,119 sh	—	—	6,014
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.Class A WarrantP Purchase	Director	PPurchase	+3,119 sh	—	—	3,119
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.Class B WarrantP Purchase	Director	PPurchase	+3,119 sh	—	—	3,119
2016-06-29	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+35K sh	$0.55	+$19.3K	35,000
2016-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−11.4K sh	—	—	22,833
2016-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.4K sh	—	—	11,417
2015-08-26	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director	AAward	+35K sh	$1.52	+$53.2K	35,000
2015-05-22	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	Director	PPurchase	+3,500 sh	$2.30	+$8,050	10,000
2015-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Buy Common StockA Award	Director	AAward	+34.3K sh	$2.30	+$78.8K	34,250
2015-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	Director	AAward	+34.3K sh	—	—	34,250
2014-12-17	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	Director	PPurchase	+2,500 sh	$1.80	+$4,500	17,616
2014-12-16	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	Director	PPurchase	+4,000 sh	$2.41	+$9,640	15,116
2013-10-16	DMK PHARMACEUTICALS CorpEmployee Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2013-03-06	DMK PHARMACEUTICALS CorpA Award	Director	AAward	+19.8K sh	—	—	19,776
2012-10-11	DMK PHARMACEUTICALS CorpEmployee Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2011-09-13	DMK PHARMACEUTICALS CorpEmployee Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2011-01-12	DMK PHARMACEUTICALS CorpEmployee Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2007-03-02	Pernix Sleep, Inc.Stock option (right to buy)A Award	Director, President and CEO	AAward	+100K sh	—	—	100,000
2007-02-15	Pernix Sleep, Inc.S Sale	Director, President and CEO	SSale	−5,000 sh	$12.96	−$64.8K	79,628
2006-10-04	Pernix Sleep, Inc.S Sale	Director, President and CEO	SSale	−84 sh	$12.50	−$1,050.067	115,224
2006-10-02	Pernix Sleep, Inc.S Sale	Director, President and CEO	SSale	−525 sh	$12.62	−$6,626.393	115,308
2006-01-06	Pernix Sleep, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+225K sh	—	—	225,000

Recent filings

Accepted (ET)
Apr 44/A
Cohen Kenneth M0001415889-18-000550
SEC(opens sec.gov)
Apr 34
Cohen Kenneth M0001415889-18-000540
SEC(opens sec.gov)
Feb 234
Cohen Kenneth M0001415889-18-000307
SEC(opens sec.gov)
Jan 244
Cohen Kenneth M0001415889-18-000114
SEC(opens sec.gov)
Oct 44
Cohen Kenneth M0001415889-17-001617
SEC(opens sec.gov)
Sep 184
Cohen Kenneth M0001415889-17-001507
SEC(opens sec.gov)
Jun 144
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000981
SEC(opens sec.gov)
May 234
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000842
SEC(opens sec.gov)
Apr 44
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000593
SEC(opens sec.gov)
Jan 34
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000021
SEC(opens sec.gov)
Aug 304
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-16-007008
SEC(opens sec.gov)
Aug 194
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-16-006923
SEC(opens sec.gov)
Jul 284
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-16-006610
SEC(opens sec.gov)
Apr 54
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-16-005446
SEC(opens sec.gov)

Companies

Address

C/O ADAMIS PHARMACEUTICALS CORPORATION 11455 EL CAMINO REAL, SUITE 310

DEL MAR, CA, 92014